Careplus Group Berhad Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Careplus Group Berhad.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei	23.0%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Feb 07

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Dec 18

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Nov 23

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Sep 07

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Apr 01

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Feb 26

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Feb 13

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Jan 17

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Dec 13

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Careplus Group Berhad onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

KLSE:CAREPLS - Toekomstschattingen van analisten en financiële gegevens uit het verleden (MYR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2024	85	-27	-90	-68	N/A
6/30/2023	205	-147	-33	-23	N/A
12/31/2022	262	-122	-103	-58	N/A
9/30/2022	325	-119	-180	-94	N/A
6/30/2022	378	-81	-161	-68	N/A
3/31/2022	541	60	-53	60	N/A
12/31/2021	700	221	58	181	N/A
9/30/2021	721	279	164	292	N/A
6/30/2021	742	314	193	331	N/A
3/31/2021	612	245	133	253	N/A
12/31/2020	476	122	50	149	N/A
9/30/2020	455	81	64	118	N/A
6/30/2020	417	33	31	63	N/A
3/31/2020	385	-5	17	39	N/A
12/31/2019	365	-6	33	48	N/A
9/30/2019	346	-8	16	26	N/A
6/30/2019	351	-2	11	21	N/A
3/31/2019	345	-1	6	18	N/A
12/31/2018	339	-1	-1	14	N/A
9/30/2018	325	-1	-4	18	N/A
6/30/2018	314	-3	8	23	N/A
3/31/2018	314	-6	N/A	19	N/A
12/31/2017	323	-2	N/A	13	N/A
9/30/2017	316	1	N/A	3	N/A
6/30/2017	295	0	N/A	-7	N/A
3/31/2017	267	3	N/A	-6	N/A
12/31/2016	229	0	N/A	4	N/A
9/30/2016	210	0	N/A	9	N/A
6/30/2016	203	3	N/A	18	N/A
3/31/2016	195	4	N/A	16	N/A
12/31/2015	190	6	N/A	18	N/A
9/30/2015	182	5	N/A	20	N/A
6/30/2015	169	5	N/A	16	N/A
3/31/2015	159	4	N/A	24	N/A
12/31/2014	152	3	N/A	20	N/A
12/31/2013	141	1	N/A	0	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if CAREPLS's forecast earnings growth is above the savings rate (3.6%).

Winst versus markt: Insufficient data to determine if CAREPLS's earnings are forecast to grow faster than the MY market

Hoge groeiwinsten: Insufficient data to determine if CAREPLS's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if CAREPLS's revenue is forecast to grow faster than the MY market.

Hoge groei-inkomsten: Insufficient data to determine if CAREPLS's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if CAREPLS's Return on Equity is forecast to be high in 3 years time

Careplus Group Berhad Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Careplus Group Berhad, Annual General Meeting, Dec 04, 2024

Insufficient new directors

Careplus Group Berhad has filed a Follow-on Equity Offering.

Full year 2024 earnings released: RM0.042 loss per share (vs RM0.26 loss in FY 2023)

Careplus Group Berhad Announces Appointment of A Ley Lim as Joint Secretary

Careplus Group Berhad announced that it expects to receive MYR 17.47356 million in funding

New minor risk - Financial data availability

Careplus Group Berhad (KLSE:CAREPLS) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Careplus Group Berhad (KLSE:CAREPLS) Shares Fly 63% But Investors Aren't Buying For Growth

Is Careplus Group Berhad (KLSE:CAREPLS) Using Debt Sensibly?

Careplus Group Berhad, Annual General Meeting, Oct 25, 2023

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New minor risk - Shareholder dilution

Little Excitement Around Careplus Group Berhad's (KLSE:CAREPLS) Revenues

Full year 2023 earnings released: RM0.26 loss per share (vs RM0.14 loss in FY 2022)

New major risk - Revenue and earnings growth

Careplus Group Berhad Announces the Re-Designation of Puan Hazrena Binti Yahaya as Non-Independent Director from Independent Director

Careplus Group Berhad Announces Resignation of Madam Yew Yee Peng as Executive Director

Careplus Group Berhad Appoints Loo Hui Yan as Joint Secretary

Full year 2022 earnings released

Ansell Services (Asia) Sdn. Bhd. agreed to acquire 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS) for MYR 37.5 million.

Careplus Group Berhad announced that it expects to receive MYR 49.8 million in funding

Careplus Group Berhad Announces Redesignation of Yee Chow Boi from Member of Remuneration Committee to Independent and Non Executive Chairman of Remuneration Committee

Now 21% undervalued

Third quarter 2022 earnings released: RM0.053 loss per share (vs RM0.015 profit in 3Q 2021)

Insufficient new directors

Careplus Group Berhad Announces Material Litigation Update

Second quarter 2022 earnings released: RM0.062 loss per share (vs RM0.20 profit in 2Q 2021)

First quarter 2022 earnings released: RM0.066 loss per share (vs RM0.23 profit in 1Q 2021)

Careplus Group Berhad, Annual General Meeting, Jun 08, 2022

Insufficient new directors

Should You Be Adding Careplus Group Berhad (KLSE:CAREPLS) To Your Watchlist Today?

Careplus Group Berhad (KLSE:CAREPLS) Seems To Use Debt Rather Sparingly

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Insufficient new directors

Is Careplus Group Berhad (KLSE:CAREPLS) A Risky Investment?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Is Now The Time To Put Careplus Group Berhad (KLSE:CAREPLS) On Your Watchlist?

Insufficient new directors

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Second quarter 2021 earnings released: EPS RM0.20 (vs RM0.067 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of RM0.02 per share

Does Careplus Group Berhad (KLSE:CAREPLS) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Careplus Group Berhad Declares Interim Dividend for the Financial Year Ending 31 December 2021, Payable on 16 June 2021

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS RM0.23 (vs RM0.011 loss in FY 2019)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investors Shouldn't Be Too Comfortable With Careplus Group Berhad's (KLSE:CAREPLS) Robust Earnings

Full year 2020 earnings released

New 90-day low: RM1.94

Could The Careplus Group Berhad (KLSE:CAREPLS) Ownership Structure Tell Us Something Useful?

Investor sentiment deteriorated over the past week

Careplus Group Berhad (KLSE:CAREPLS) Could Easily Take On More Debt

Investor sentiment improved over the past week

New 90-day low: RM2.07

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

New 90-day low: RM2.34

Our View On Careplus Group Berhad's (KLSE:CAREPLS) CEO Pay

Careplus Group Berhad (KLSE:CAREPLS) and Tang Kin San completed the acquisition of Centro Heights Sdn. Bhd. from Chang Keng Chiang, Chang Sze Wei and Chang Kai Ping.

Market pulls back on stock over the past week

Market pulls back on stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Ansell Limited (ASX:ANN) completed the acquisition 50% stake in CAREPLUS (M) SDN. BHD from Careplus Group Berhad (KLSE:CAREPLS).

Careplus Group Berhad (KLSE:CAREPLS) and Tang Kin San signed a conditional share purchase agreement to acquire Centro Heights Sdn. Bhd. from Chang Keng Chiang, Chang Sze Wei and Chang Kai Ping for RM 3.8 million.

New 90-day high - RM1.90